Literature DB >> 19718794

Characterization of PLGA nanospheres stabilized with amphiphilic polymers: hydrophobically modified hydroxyethyl starch vs pluronics.

Ahmed Besheer1, Jürgen Vogel, Dagobert Glanz, Jörg Kressler, Thomas Groth, Karsten Mäder.   

Abstract

Some Pluronics, particularly F127, are known to stabilize nanospheres and prolong their circulation time in vivo. However, these copolymers of poly(ethylene glycol) (PEG) and poly(propylene glycol) are not biodegradable, and despite the long history, there is no approved commercial product using F127 for parenteral administration until now. Meanwhile, hydroxyethyl starch (HES) is a biodegradable polymer that is currently investigated as a substitute for PEG. In order to produce a fully biodegradable amphiphilic polymer, we esterified different molar masses of HES with lauric acid to get different molar substitutions. These polymers, as well as Pluronic F68 and F127, were used to stabilize poly(lactic-co-glycolic acid) (PLGA) nanospheres prepared by nanoprecipitation. For physicochemical characterization, the particle size, zeta potential, and the thickness of the adsorbed polymer layer were measured. The ability of the polymer coating to prevent the adsorption of human serum albumin (HSA) and fibrinogen (FBG) was evaluated. Finally, the phagocytosis of the stabilized nanospheres by a monocyte macrophage cell line (J774.2) was assessed. Results show that the PLGA nanospheres had an average particle size of 110-140 nm. The thickness of the adsorbed polymer layer increases with the increase in molar mass, and is generally higher for HES laurates than the studied Pluronics. Pluronic F68, F127 as well as the HES laurates with low molar substitution prevented the adsorption of HSA. HES laurates with low molar substitution and F127, but not F68, prevented the adsorption of FBG. The phagocytosis experiments showed that the HES laurates, particularly the one with the highest molar mass, could reduce the uptake of the nanospheres better than F68 and comparable to F127. Finally, these results warrant in vivo experiments to evaluate how the HES laurates can affect the pharmacokinetics and fate of the nanospheres.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19718794     DOI: 10.1021/mp800119h

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  14 in total

1.  Evaluation of new bi-functional terpolymeric nanoparticles for simultaneous in vivo optical imaging and chemotherapy of breast cancer.

Authors:  Alireza Shalviri; Ping Cai; Andrew M Rauth; Jeffery T Henderson; Xiao Yu Wu
Journal:  Drug Deliv Transl Res       Date:  2012-12       Impact factor: 4.617

Review 2.  Hydroxyethyl starch and its derivatives as nanocarriers for delivery of diagnostic and therapeutic agents towards cancers.

Authors:  Ronghua Tan; Ying Wan; Xiangliang Yang
Journal:  Biomater Transl       Date:  2020-12-28

3.  Engineered andrographolide nanoparticles mitigate paracetamol hepatotoxicity in mice.

Authors:  Partha Roy; Suvadra Das; Runa Ghosh Auddy; Achintya Saha; Arup Mukherjee
Journal:  Pharm Res       Date:  2013-01-15       Impact factor: 4.200

4.  Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice.

Authors:  Tapan K Jain; Susan P Foy; Bernadette Erokwu; Sanja Dimitrijevic; Christopher A Flask; Vinod Labhasetwar
Journal:  Biomaterials       Date:  2009-09-17       Impact factor: 12.479

5.  Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles.

Authors:  Jun Wang; Baoan Chen; Jian Chen; Xiaohui Cai; Guohua Xia; Ran Liu; Pingsheng Chen; Yu Zhang; Xuemei Wang
Journal:  Int J Nanomedicine       Date:  2011-01-24

6.  Intranasal M cell uptake of nanoparticles is independently influenced by targeting ligands and buffer ionic strength.

Authors:  Thejani E Rajapaksa; Kaila M Bennett; Mary Hamer; Christian Lytle; Victor G J Rodgers; David D Lo
Journal:  J Biol Chem       Date:  2010-05-28       Impact factor: 5.157

7.  The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance.

Authors:  Chung Ping Leon Wan; Kevin Letchford; John K Jackson; Helen M Burt
Journal:  Int J Nanomedicine       Date:  2013-01-22

8.  Optimizing the synthesis of CdS/ZnS core/shell semiconductor nanocrystals for bioimaging applications.

Authors:  Li-Wei Liu; Si-Yi Hu; Ying Pan; Jia-Qi Zhang; Yue-Shu Feng; Xi-He Zhang
Journal:  Beilstein J Nanotechnol       Date:  2014-06-27       Impact factor: 3.649

9.  Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration.

Authors:  Aly A Abdelbary; Abdulaziz M Al-mahallawi; Mohamed E Abdelrahim; Ahmed M A Ali
Journal:  Int J Nanomedicine       Date:  2015-10-12

10.  Preparation, characterization and systemic application of self-assembled hydroxyethyl starch nanoparticles-loaded flavonoid Morin for hyperuricemia therapy.

Authors:  Jianbo Li; Yang Yang; Likang Lu; Qiujin Ma; Jinjie Zhang
Journal:  Int J Nanomedicine       Date:  2018-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.